Results 121 to 130 of about 24,867 (235)

Danger of co-administration ferric carboxymaltose and denosumab: hypophosphatemia

open access: yesThe Egyptian Journal of Internal Medicine
Both denosumab-induced hypocalcemia and ferric carboxymaltose infusion-related hypophosphatemia have been extensively documented. There are significant risks associated with combining ferric carboxymaltose parenteral infusions and denosumab, including ...
Aysun Seker, Nurdan Senturk Durmus
doaj   +1 more source

Genetic diseases of renal phosphate handling [PDF]

open access: yes, 2006
UNLABELLED: Renal control of systemic phosphate homeostasis is critical as evident from inborn and acquired diseases causing renal phosphate wasting. At least three transport proteins are responsible for renal phosphate reabsorption: NAPI-IIa (SLC34A1 ...
Wagner, Carsten A.   +3 more
core   +2 more sources

Genetic and clinical peculiarities in a new family with hereditary hypophosphatemic rickets with hypercalciuria: a case report [PDF]

open access: yes, 2010
Hereditary hypophosphatemic rickets with hypercalciuria is a rare autosomal recessive disorder (OMIM #241530), characterized by decreased renal phosphate reabsorption that leads to hypophosphatemia, rickets, and bone pain; hypophosphatemia is believed to
Coto, Eliecer   +3 more
core  

Nirogacestat and Hypophosphatemia

open access: yesKidney International Reports, 2023
Gudsoorkar, Prakash   +2 more
openaire   +2 more sources

Hypophosphatemia as a biomarker of metabolic intolerance to enhanced nutrition in the PICU: a secondary analysis of the PEPaNIC RCT. [PDF]

open access: yesCrit Care
Vanhorebeek I   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy